syndecan-4 (ng/ml) | Remission | Low disease activity | Moderate disease activity | High disease activity | p |
---|---|---|---|---|---|
DAS28-ESR | 432.2 (287.4–738.5) (n = 16) | 519.2 (177.1–519.2) (n = 3) | 484.8 (343.6–677.8) (n = 25) | 680.1 (466.3–1241.5) (n = 16) | 0.082 |
DAS28-CRP | 499.2 (203.3–537.5)(n = 15) | 406.3 (320.3–762.9) (n = 15) | 490.8 (373.8–708.3) (n = 15) | 704.4 (517.4–1263.3) (n = 15) | 0.049 |
SDAI | 203.3 (164.8–203.3)(n = 3) | 464.2 (316.2–743.4) (n = 25) | 434.3 (352.4–501.0) (n = 13) | 704.4 (517.4–1176.2) (n = 19) | 0.014 |
CDAI | 203.3 (164.8–203.3)(n = 3) | 464.2 (316.2–743.4) (n = 25) | 434.3 (352.4–501.0) (n = 13) | 704.4 (517.4–1176.2) (n = 19) | 0.014 |